Oncology Start-up Firm Peloton Closes $18M Series A Financing
By Jennifer Boggs
Thursday, July 28, 2011
Recently formed early stage cancer drug company Peloton Therapeutics Inc. raised $18 million in a Series A financing that reunited Tularik Inc. co-founders Steven L. McKnight and David Goeddel.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.